These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26493311)

  • 41. The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.
    Maayah ZH; El-Kadi AO
    Arch Toxicol; 2016 Jan; 90(1):119-36. PubMed ID: 26525395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
    Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
    Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
    J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy.
    Chen S; Khan ZA; Karmazyn M; Chakrabarti S
    Diabetes Metab Res Rev; 2007 Jul; 23(5):356-67. PubMed ID: 17024690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
    Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
    J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta.
    Smeets PJ; Teunissen BE; Planavila A; de Vogel-van den Bosch H; Willemsen PH; van der Vusse GJ; van Bilsen M
    J Biol Chem; 2008 Oct; 283(43):29109-18. PubMed ID: 18701451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel role of G protein-coupled receptor kinase 5 in urotensin II-stimulated cellular hypertrophy in H9c2
    Park CH; Lee JH; Lee MY; Lee JH; Lee BH; Oh KS
    Mol Cell Biochem; 2016 Nov; 422(1-2):151-160. PubMed ID: 27613164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
    Planavila A; Iglesias R; Giralt M; Villarroya F
    Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway.
    Li H; Tan J; Zou Z; Huang CG; Shi XY
    Eur J Anaesthesiol; 2011 Jul; 28(7):525-34. PubMed ID: 21666544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ginseng (Panax quinquefolius) attenuates leptin-induced cardiac hypertrophy through inhibition of p115Rho guanine nucleotide exchange factor-RhoA/Rho-associated, coiled-coil containing protein kinase-dependent mitogen-activated protein kinase pathway activation.
    Moey M; Rajapurohitam V; Zeidan A; Karmazyn M
    J Pharmacol Exp Ther; 2011 Dec; 339(3):746-56. PubMed ID: 21875949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracellular heat shock protein HSC70 protects against lipopolysaccharide-induced hypertrophic responses in rat cardiomyocytes.
    Jan RL; Yang SC; Liu YC; Yang RC; Tsai SP; Huang SE; Yeh JL; Hsu JH
    Biomed Pharmacother; 2020 Aug; 128():110370. PubMed ID: 32521457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.
    Kilić A; Javadov S; Karmazyn M
    J Mol Cell Cardiol; 2009 Mar; 46(3):360-9. PubMed ID: 19111554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.
    Alsaad AM; Zordoky BN; Tse MM; El-Kadi AO
    Drug Metab Rev; 2013 May; 45(2):173-95. PubMed ID: 23600686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes.
    Li T; Wang Y; Liu C; Hu Y; Wu M; Li J; Guo L; Chen L; Chen Q; Ha T; Li C; Li Y
    J Hypertens; 2009 May; 27(5):1084-93. PubMed ID: 19342961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
    Dong B; Xue R; Sun Y; Dong Y; Liu C
    Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deubiquitinase Inhibitor Auranofin Attenuated Cardiac Hypertrophy by Blocking NF-κB Activation.
    Hu M; Zhang Z; Liu B; Zhang S; Chai R; Chen X; Kong T; Zhang F; Zhang J; Liu S; Liu N
    Cell Physiol Biochem; 2018; 45(6):2421-2430. PubMed ID: 29554646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes.
    Tang L; Yao F; Wang H; Wang X; Shen J; Dai B; Wu H; Zhou D; Guo F; Wang J; Li T; Wang H; Gong T; Su J; Wang L; Liang P
    J Mol Cell Cardiol; 2019 Jan; 126():143-154. PubMed ID: 30423318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.